Watchung, NJ, United States of America

Shuan Dong

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2013.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuan Dong: Innovator in Chemical Synthesis

Introduction

Shuan Dong is a notable inventor based in Watchung, NJ (US). He has made significant contributions to the field of chemical synthesis, particularly in the development of innovative processes for creating complex compounds. His work is characterized by a focus on efficiency and effectiveness in chemical reactions.

Latest Patents

Shuan Dong holds a patent for a process titled "Process for the synthesis of 3-amino-3-cyclobuthylmethyl-2-hydroxypropionamide or salts thereof." This patent describes a method for preparing 3-amino-3-cyclobutylmethyl-2-hydroxypropionamide, which involves providing a compound in a solution predominantly comprising dimethylsulfoxide (DMSO). The process allows for the direct conversion of this compound to the desired product without the need for isolating intermediate compounds.

Career Highlights

Shuan Dong is currently employed at Merck Sharp & Dohme Corp., a leading global healthcare company. His role involves research and development in the field of pharmaceuticals, where he applies his expertise in chemical synthesis to advance innovative solutions.

Collaborations

Shuan has collaborated with several talented individuals in his field, including Jeonghan Park and Eugene John Vater. These collaborations have contributed to the advancement of research and development projects within the company.

Conclusion

Shuan Dong's contributions to chemical synthesis and his innovative patent demonstrate his commitment to advancing the field. His work at Merck Sharp & Dohme Corp. continues to impact the pharmaceutical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…